The Serum Institute of India (SII) CEO, Adar Poonawalla has said that he is hopeful of launching Covovax. The Serum Institute of India is developing ‘Covavax’ in partnership with American pharmaceutical firm Novavax, by June 2021.
Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!
— Adar Poonawalla (@adarpoonawalla) January 30, 2021
Novavax announced that the vaccine was found to be 89.3% effective during the phase 3 trial in UK. Adar Poonawalla in twitter said “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!.”